# KRINTAFEL
> **NDA210795** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2018-07-20
## Drug
- **FDA Application Number:** NDA210795
- **Application type:** New Drug Application
- **Brand name:** KRINTAFEL
- **Generic name:** TAFENOQUINE SUCCINATE
- **Active ingredients:** TAFENOQUINE SUCCINATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2018-07-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210795)
---
*MORVS · CC0 1.0*